Role of B cell activating factor in non-infectious complications of common variable immunodeficiency
B细胞激活因子在常见变异型免疫缺陷非感染性并发症中的作用
基本信息
- 批准号:10326836
- 负责人:
- 金额:$ 18.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAffinityAntibodiesAntigensApoptosisAutoantibodiesAutoimmuneAutoimmunityAutomobile DrivingB Cell ProliferationB-Cell ActivationB-Lymphocyte SubsetsB-LymphocytesBCL2 geneBioinformaticsBiologyBiopsyBloodCAMLG geneCell MaturationCell SurvivalCell physiologyCellsCellular biologyCharacteristicsChronicClinicalClinical ImmunologyCommittee MembersCommon Variable ImmunodeficiencyCytometryDataDefectDevelopmentDoctor of PhilosophyEnvironmentFellowshipFosteringFundingGene ExpressionGeneticGenetic TranscriptionGoalsHumanHypersensitivityImmuneImmunofluorescence ImmunologicImmunoglobulin DImmunoglobulin MImmunologicsImmunologyImmunosuppressive AgentsImpairmentInhibition of ApoptosisInterferonsInterleukin 4 ReceptorInternal MedicineInternationalInterstitial Lung DiseasesLaboratoriesLeadLesionLeukocytesLinkLungLymphoid CellMalignant NeoplasmsMediatingMedical centerMedicineMemoryMemory LossMentorsMentorshipMorbidity - disease rateMusMutationOrganOutcomePathogenesisPathogenicityPatientsPhysiciansPlasma CellsPositioning AttributeProductionProtein FamilyRecurrenceResearchResearch MethodologyResearch PersonnelResidenciesResistanceRoleRunningSTAT1 geneScientistSignal TransductionSourceStimulusStudy SubjectSystems BiologyT-LymphocyteTestingTissuesToxic effectTrainingTraining ProgramsUnited States National Institutes of HealthWorkacademic programauthoritybasecareercareer developmentcongenital immunodeficiencycytokineeffective therapyhumoral immunity deficiencyimprovedinfection risklymphoid hyperplasiamedical schoolsmonocytemortalitynew therapeutic targetnovel therapeutic interventionoverexpressionpatient orientedplasma cell developmentprofessorprogramsreceptorrecruitresponsetranscriptome sequencing
项目摘要
Project Summary
The goal of this proposal is to support the PI’s development into an independent patient-oriented researcher
with expertise in common variable immunodeficiency (CVID) and B cell biology. The PI will be mentored in all
aspects of the proposal and receive training in systems biology approaches to human immunology research.
Candidate - The PI holds MD and PhD degrees, has completed internal medicine residency and
allergy/immunology fellowship at Mount Sinai Medical Center, and has been appointed Assistant Professor in
Department of Medicine at the Icahn School of Medicine at Mount Sinai. He has joined the laboratory of Dr.
Charlotte Cunningham-Rundles and his preliminary work defined the immunological characteristics of CVID
non-infectious complications. Elucidating pathogenesis of these complications is the focus of this proposal.
Research – CVID is the most common symptomatic primary immunodeficiency. Its greatest morbidity and
mortality results from non-infectious complications, namely autoimmunity (AI) and lymphoid hyperplasia (LH).
The PI has previously detailed the cellular characteristics of pulmonary LH underlying interstitial lung disease
(ILD) in these patients and defined clinical and laboratory associations of these complications. Recently, the PI
found B cell activating factor (BAFF) elevated in the CVID patients with progressive AI and LH and the cytokine
to be produced locally in the lungs of patients with ILD. Also, BAFF receptor (BAFF-R) expression and
signaling is localized to follicles within LH, B cell maturation is most profoundly arrested in CVID patients with
AI and LH, and apoptosis resistance of the persisting immature B cell subsets is mediated by BAFF. We
hypothesize that AI and LH result from excessive BAFF-R signaling in immature B cell subsets in CVID.
Career Development - The primary mentor (Dr. Cunningham-Rundles) is the David S. Gottesman Professor
of Immunology at Mount Sinai and is an international authority on CVID. She runs the NIH-funded lab in which
the PI will be based and directs the large clinical immunology practice from which study subjects will be
recruited. Co-mentor Dr. Andrea Cerutti is an expert in T cell-independent activation of B cells via cytokines
such as BAFF and is a Professor of Medicine at Mount Sinai. Additional advisory committee members are
respected investigators with diverse expertise that will supplement the candidate’s research mentorship and
career development. The candidate will also benefit from the collaborative research environment of the Icahn
School of Medicine at Mount Sinai and complete coursework in bioinformatics and systems biology.
Synopsis – Drawing upon a focused research approach, expert mentorship, and a strategic educational plan,
this proposal details a 5 year training program for an academic career in primary immunodeficiency and human
B cell biology. At the conclusion of training, the PI will be positioned to become an independent physician
scientist with expertise in CVID, BAFF biology, and high throughput human immunology research methods.
项目摘要
这项建议的目标是支持PI发展成为一个独立的以病人为导向的研究者
具有常见变异免疫缺陷(CVID)和B细胞生物学方面的专业知识。PI将接受所有
该计划的各个方面,并接受系统生物学方法的培训,以人类免疫学研究。
候选人-PI拥有MD和PhD学位,已完成内科住院医师培训,
过敏/免疫学奖学金在西奈山医疗中心,并已被任命为助理教授,
西奈山伊坎医学院医学系。彼已加入博士之实验室。
夏洛特Cunningham-Rundles和他的前期工作确定了CVID的免疫学特征
非感染性并发症。阐明这些并发症的发病机制是本建议的重点。
研究- CVID是最常见的症状性原发性免疫缺陷。其最大的发病率和
非感染性并发症,即自身免疫(AI)和淋巴增生(LH)导致死亡。
PI先前已详细描述了间质性肺病基础肺LH的细胞特征
(ILD)并确定了这些并发症的临床和实验室相关性。最近,PI
发现B细胞活化因子(BAFF)在CVID患者中升高,伴有进行性AI和LH,
在ILD患者的肺部局部产生。此外,BAFF受体(BAFF-R)表达和
信号传导定位于LH内的卵泡,B细胞成熟在CVID患者中最严重地被阻滞,
BAFF介导AI和LH,以及持续未成熟B细胞亚群的凋亡抵抗。我们
假设AI和LH是由CVID中未成熟B细胞亚群中过量BAFF-R信号传导引起的。
职业发展-主要导师(坎宁安-伦德尔博士)是大卫S。Gottesman教授
他是西奈山的免疫学教授,也是CVID的国际权威。她管理着一个由国家卫生研究院资助的实验室,
PI将基于并指导大型临床免疫学实践,
招募的共同导师Andrea Cerutti博士是通过细胞因子非依赖T细胞激活B细胞的专家
他是西奈山医学院的教授。其他咨询委员会成员包括
受人尊敬的研究人员具有不同的专业知识,将补充候选人的研究指导,
职业发展。候选人还将受益于伊坎的合作研究环境
西奈山医学院,完成生物信息学和系统生物学课程。
概要-利用重点研究方法,专家指导和战略教育计划,
该提案详细介绍了一个为期5年的培训计划,为学术生涯在初级免疫缺陷和人类
B细胞生物学在培训结束时,PI将成为一名独立的医生
在CVID、BAFF生物学和高通量人类免疫学研究方法方面具有专长的科学家。
项目成果
期刊论文数量(20)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Genomic characterization of lymphomas in patients with inborn errors of immunity.
- DOI:10.1182/bloodadvances.2021006654
- 发表时间:2022-09-27
- 期刊:
- 影响因子:7.5
- 作者:Ye, Xiaofei;Maglione, Paul J.;Wehr, Claudia;Li, Xiaobo;Wang, Yating;Abolhassani, Hassan;Deripapa, Elena;Liu, Dongbing;Borte, Stephan;Du, Likun;Wan, Hui;Ploetner, Andreas;Giannoula, Yvonne;Ko, Huai-Bin;Hou, Yong;Zhu, Shida;Grossman, Jennifer K.;Sander, Birgitta;Grimbacher, Bodo;Hammarstrom, Lennart;Fedorova, Alina;Rosenzweig, Sergio D.;Shcherbina, Anna;Wu, Kui;Warnatz, Klaus;Cunningham-Rundles, Charlotte;Pan-Hammarstrom, Qiang
- 通讯作者:Pan-Hammarstrom, Qiang
The lung in inborn errors of immunity: From clinical disease patterns to molecular pathogenesis.
- DOI:10.1016/j.jaci.2022.08.024
- 发表时间:2022-12
- 期刊:
- 影响因子:14.2
- 作者:Gutierrez, Maria J.;Nino, Gustavo;Sun, Di;Restrepo-Gualteros, Sonia;Sadreameli, Sarah C.;Fiorino, Elizabeth K.;Wu, Eveline;Vece, Timothy;Hagood, James S.;Maglione, Paul J.;Kurland, Geoffrey;Koumbourlis, Anastassios;Sullivan, Kathleen E.
- 通讯作者:Sullivan, Kathleen E.
Gut T cell-independent IgA responses to commensal bacteria require engagement of the TACI receptor on B cells.
- DOI:10.1126/sciimmunol.aat7117
- 发表时间:2020-07-31
- 期刊:
- 影响因子:24.8
- 作者:Grasset EK;Chorny A;Casas-Recasens S;Gutzeit C;Bongers G;Thomsen I;Chen L;He Z;Matthews DB;Oropallo MA;Veeramreddy P;Uzzan M;Mortha A;Carrillo J;Reis BS;Ramanujam M;Sintes J;Magri G;Maglione PJ;Cunningham-Rundles C;Bram RJ;Faith J;Mehandru S;Pabst O;Cerutti A
- 通讯作者:Cerutti A
B Cell Dysregulation in Common Variable Immunodeficiency Interstitial Lung Disease.
- DOI:10.3389/fimmu.2020.622114
- 发表时间:2020
- 期刊:
- 影响因子:7.3
- 作者:Matson EM;Abyazi ML;Bell KA;Hayes KM;Maglione PJ
- 通讯作者:Maglione PJ
B cells promote granulomatous inflammation during chronic Mycobacterium tuberculosis infection in mice.
B细胞在小鼠的慢性分枝杆菌感染期间促进肉芽肿性炎症。
- DOI:10.1371/journal.ppat.1011187
- 发表时间:2023-03
- 期刊:
- 影响因子:6.7
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul Joseph Maglione其他文献
Paul Joseph Maglione的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 18.87万 - 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
- 批准号:
2750554 - 财政年份:2021
- 资助金额:
$ 18.87万 - 项目类别:
Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
- 批准号:
61319 - 财政年份:2020
- 资助金额:
$ 18.87万 - 项目类别:
Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10013588 - 财政年份:2020
- 资助金额:
$ 18.87万 - 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
- 批准号:
20K07009 - 财政年份:2020
- 资助金额:
$ 18.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
- 批准号:
10603473 - 财政年份:2020
- 资助金额:
$ 18.87万 - 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
- 批准号:
2342674 - 财政年份:2020
- 资助金额:
$ 18.87万 - 项目类别:
Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
- 批准号:
10117194 - 财政年份:2020
- 资助金额:
$ 18.87万 - 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10115604 - 财政年份:2020
- 资助金额:
$ 18.87万 - 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
- 批准号:
10294224 - 财政年份:2018
- 资助金额:
$ 18.87万 - 项目类别: